Atlas Trials

Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Clinical trial NCT00551759 · TERMINATED

Trial details

NCT number
NCT00551759
Sponsor
Eastern Cooperative Oncology Group
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2008-10-02
Primary completion
2011-10-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.